Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman
20/10/2022 07:03
Oct 20 (Reuters) - Vista Pharmaceuticals Ltd VIPH.BO :
* APPOINTS DR. DHANANJAYA ALLI AS CHAIRMAN
* NAMES MURALI MERAGA AS MD
Source text for Eikon: ID:nBSE57NCMp
Further company coverage: VIPH.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vista Pharmaceuticals
See all newsBrief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
Brief: Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
Brief: Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
Brief: Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman